Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,investments,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,exchange,marketState,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,priceHint,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry,address2
t0,INSP,223131000,27213500,8154000,,-16193000,,-16216000,41906000,34371000,-15689000,-15689000,,-523000,,,,23000,40352000,56041000,5981000,-504000,,-16216000,-16216000,476658000,50282000,223131000,273413000,27000,-253563000,97000,9000,204000,182348000,19422000,9000,12425000,260784000,43796000,21646000,24804000,11385000,9057000,1477000.0,-1321000.0,3550000.0,-2693000.0,3550000.0,-8170000.0,2000.0,-10401000.0,234000.0,-2905000.0,3381000.0,6263000.0,-1321000.0,,241362000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,224.27,1630526402,0.7100067,225.21,226.34,222.15,186285,"Inspire Medical Systems, Inc.",NYQ,PRE,0.116924405,0,False,False,0.31759113,222.15 - 226.34,223.56,0.0,224.07,8,8,finmb_59661803,NYSE,"Inspire Medical Systems, Inc.",USD,271187,195285,114.21001,1.0377067,110.06 - 252.25,-27.979996,-0.11092169,110.06,252.25,1620144770,1635764340,1636113600,-2.132,-1.57,2,-2.25,-99.67556,8.202,194.98486,29.285141,0.15019187,200.79247,23.47754,6103171584,-142.84714,27.343332,15,America/New_York,EDT,-14400000,1.65,,,252.25,110.06,194.98,200.79,271.19k,195.28k,27.21M,,26.44M,2.85%,96.01%,715.13k,2.75,3.03%,2.63%,686.14k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-42.54%,-41.27%,-15.78%,-32.62%,134.39M,5.01,89.00%,97.76M,-54.57M,-57.17M,-2.13,,226.14M,8.31,30.76M,13.79,13.43,8.20,-48.67M,-30.67M,Value,55416,Healthcare,341,9,6,"Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.",Golden Valley,844 672 4357,MN,8,1609372800,1622505600,8,United States,http://www.inspiresleep.com,86400,8,5500 Wayzata Boulevard,Medical Devices,Suite 1600
t-1,INSP,229747000,27213500,7285000,,-7456000,,-7484000,38625000,38848000,-7062000,-7062000,,-533000,,,,28000,46009000,53071000,7161000,-394000,,-7484000,-7484000,467038000,51442000,229747000,281189000,27000,-237347000,85000,29000,204000,190518000,20725000,29000,11116000,269869000,43844000,25063000,24746000,8479000,7209000,-214000.0,11396000.0,4521000.0,2507000.0,4521000.0,11813000.0,6000.0,-4110000.0,253000.0,487000.0,-3921000.0,4204000.0,-604000.0,12000000.0,249144000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,224.27,1630526402,0.7100067,225.21,226.34,222.15,186285,"Inspire Medical Systems, Inc.",NYQ,PRE,0.116924405,0,False,False,0.31759113,222.15 - 226.34,223.56,0.0,224.07,8,8,finmb_59661803,NYSE,"Inspire Medical Systems, Inc.",USD,271187,195285,114.21001,1.0377067,110.06 - 252.25,-27.979996,-0.11092169,110.06,252.25,1620144770,1635764340,1636113600,-2.132,-1.57,2,-2.25,-99.67556,8.202,194.98486,29.285141,0.15019187,200.79247,23.47754,6103171584,-142.84714,27.343332,15,America/New_York,EDT,-14400000,1.65,,,252.25,110.06,194.98,200.79,271.19k,195.28k,27.21M,,26.44M,2.85%,96.01%,715.13k,2.75,3.03%,2.63%,686.14k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-42.54%,-41.27%,-15.78%,-32.62%,134.39M,5.01,89.00%,97.76M,-54.57M,-57.17M,-2.13,,226.14M,8.31,30.76M,13.79,13.43,8.20,-48.67M,-30.67M,Value,55416,Healthcare,341,9,6,"Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.",Golden Valley,844 672 4357,MN,8,1609372800,1622505600,8,United States,http://www.inspiresleep.com,86400,8,5500 Wayzata Boulevard,Medical Devices,Suite 1600
t-2,INSP,228823000,27213500,7307000,,-10298000,,-10385000,33216000,30631000,-9892000,-9892000,,-533000,,,,87000,35842000,45734000,5211000,-406000,,-10385000,-10385000,458586000,42961000,228823000,271784000,27000,-229863000,74000,73000,381000,178705000,18198000,73000,4480000,266923000,55932000,21101000,24689000,8966000,6743000,1623000.0,-25929000.0,2312000.0,5746000.0,2312000.0,-32532000.0,-6000.0,-8909000.0,212000.0,999000.0,-10826000.0,3666000.0,-1215000.0,-24714000.0,248725000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,224.27,1630526402,0.7100067,225.21,226.34,222.15,186285,"Inspire Medical Systems, Inc.",NYQ,PRE,0.116924405,0,False,False,0.31759113,222.15 - 226.34,223.56,0.0,224.07,8,8,finmb_59661803,NYSE,"Inspire Medical Systems, Inc.",USD,271187,195285,114.21001,1.0377067,110.06 - 252.25,-27.979996,-0.11092169,110.06,252.25,1620144770,1635764340,1636113600,-2.132,-1.57,2,-2.25,-99.67556,8.202,194.98486,29.285141,0.15019187,200.79247,23.47754,6103171584,-142.84714,27.343332,15,America/New_York,EDT,-14400000,1.65,,,252.25,110.06,194.98,200.79,271.19k,195.28k,27.21M,,26.44M,2.85%,96.01%,715.13k,2.75,3.03%,2.63%,686.14k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-42.54%,-41.27%,-15.78%,-32.62%,134.39M,5.01,89.00%,97.76M,-54.57M,-57.17M,-2.13,,226.14M,8.31,30.76M,13.79,13.43,8.20,-48.67M,-30.67M,Value,55416,Healthcare,341,9,6,"Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.",Golden Valley,844 672 4357,MN,8,1609372800,1622505600,8,United States,http://www.inspiresleep.com,86400,8,5500 Wayzata Boulevard,Medical Devices,Suite 1600
t-3,INSP,233594000,27213500,6062000,,-23089000,,-23089000,26981000,10229000,-22814000,-22814000,,-526000,,,,0,12183000,34997000,1954000,-275000,,-23089000,-23089000,452891000,37714000,233594000,271308000,27000,-219478000,40000,154000,469000,211237000,13042000,154000,3731000,267108000,31322000,10235000,24632000,9966000,5103000,-733000.0,33919000.0,126445000.0,-2973000.0,126445000.0,135120000.0,7000.0,-25251000.0,188000.0,-2720000.0,813000.0,3207000.0,-381000.0,34300000.0,254066000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,224.27,1630526402,0.7100067,225.21,226.34,222.15,186285,"Inspire Medical Systems, Inc.",NYQ,PRE,0.116924405,0,False,False,0.31759113,222.15 - 226.34,223.56,0.0,224.07,8,8,finmb_59661803,NYSE,"Inspire Medical Systems, Inc.",USD,271187,195285,114.21001,1.0377067,110.06 - 252.25,-27.979996,-0.11092169,110.06,252.25,1620144770,1635764340,1636113600,-2.132,-1.57,2,-2.25,-99.67556,8.202,194.98486,29.285141,0.15019187,200.79247,23.47754,6103171584,-142.84714,27.343332,15,America/New_York,EDT,-14400000,1.65,,,252.25,110.06,194.98,200.79,271.19k,195.28k,27.21M,,26.44M,2.85%,96.01%,715.13k,2.75,3.03%,2.63%,686.14k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-42.54%,-41.27%,-15.78%,-32.62%,134.39M,5.01,89.00%,97.76M,-54.57M,-57.17M,-2.13,,226.14M,8.31,30.76M,13.79,13.43,8.20,-48.67M,-30.67M,Value,55416,Healthcare,341,9,6,"Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.",Golden Valley,844 672 4357,MN,8,1609372800,1622505600,8,United States,http://www.inspiresleep.com,86400,8,5500 Wayzata Boulevard,Medical Devices,Suite 1600
